Endoscopic sleeve gastroplasty for weight loss
Part of Hormones & metabolism clinical trials.
This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your BMI (body mass index) is 30 or higher — your doctor can tell you your number.
- You have tried diet, exercise, or weight-loss medication without lasting success.
- You are not eligible for weight-loss surgery, or you choose not to have it.
- You are able to have general anesthesia (the medicine that puts you fully asleep during the procedure).
- You are covered by the French social security system and are willing to follow all study requirements for the full study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new procedure called endoscopic sleeve gastroplasty with fundal mucosal ablation to help with weight loss. It is an option for people with obesity who have not had success with other methods and who have not had prior stomach surgery.
This trial tests a non-surgical procedure called Endoscopic Sleeve Gastroplasty (ESG) to help people with obesity lose weight. A doctor uses a thin tube with a camera to stitch your stomach smaller, so you feel full sooner.
This study tests a stomach procedure (endoscopy) to help people with obesity lose weight or control health problems linked to weight. You may be considered if other weight-loss efforts have not worked and surgery is not the best option for you.
This study compares two similar minimally invasive procedures to help with weight loss. The goal is to see which technique is safer and more effective for people with a high body mass index (BMI).
This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.
This study tests a weight-loss procedure called endoscopic sleeve gastroplasty (a stomach-reducing procedure done through a scope) in people with both obesity and inflammatory bowel disease (IBD). It aims to see if the procedure is safe and helpful for this group.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.